JP2009512691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009512691A5 JP2009512691A5 JP2008536608A JP2008536608A JP2009512691A5 JP 2009512691 A5 JP2009512691 A5 JP 2009512691A5 JP 2008536608 A JP2008536608 A JP 2008536608A JP 2008536608 A JP2008536608 A JP 2008536608A JP 2009512691 A5 JP2009512691 A5 JP 2009512691A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- compound
- composition according
- formula xiv
- macrocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 8
- 150000002678 macrocyclic compounds Chemical class 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- ZVGNESXIJDCBKN-UUEYKCAUSA-N Fidaxomicin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@H]([C@H]1O)OC)OCC\1=C/C=C/C[C@H](O)/C(C)=C/[C@@H]([C@H](/C(C)=C/C(/C)=C/C[C@H](OC/1=O)[C@@H](C)O)O[C@H]1[C@H]([C@@H](O)[C@H](OC(=O)C(C)C)C(C)(C)O1)O)CC)C(=O)C1=C(O)C(Cl)=C(O)C(Cl)=C1CC ZVGNESXIJDCBKN-UUEYKCAUSA-N 0.000 claims 1
- 229960000628 fidaxomicin Drugs 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
Claims (8)
- チアクミシンＢと、次の化合物：
- 少なくとも90重量％のチアクミシンＢを含む、請求項１に記載の医薬組成物。
- 全部で少なくとも1重量％の大環式化合物を含む、請求項１または２に記載の医薬組成物。
- 医薬組成物が、図5で実質的に示されるHPLCプロファイルを示す、請求項１〜３のいずれか１つに記載の医薬組成物。
- 大環式化合物として、式XIVの化合物（リピアルマイシンＡ４）を含む、請求項１〜４のいずれか１つに記載の医薬組成物。
- 医薬組成物が、0.3重量％〜5重量％の式XIVの化合物を含む、請求項１〜５のいずれか1つに記載の医薬組成物。
- 大環式化合物として、式XIVの化合物と少なくとも１つのさらなる大環式化合物とを含む、請求項５または６に記載の医薬組成物。
- 医薬組成物が、次の化合物：
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72913505P | 2005-10-21 | 2005-10-21 | |
| US74964105P | 2005-12-12 | 2005-12-12 | |
| PCT/US2006/041436 WO2007048059A2 (en) | 2005-10-21 | 2006-10-23 | Method of treating clostridium difficile-associated diarrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009512691A JP2009512691A (ja) | 2009-03-26 |
| JP2009512691A5 true JP2009512691A5 (ja) | 2009-12-10 |
Family
ID=37963388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008536608A Pending JP2009512691A (ja) | 2005-10-21 | 2006-10-23 | クロストリジウムディフィシレ関連の下痢の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1940417A4 (ja) |
| JP (1) | JP2009512691A (ja) |
| KR (1) | KR101399621B1 (ja) |
| CN (2) | CN101340919B (ja) |
| AU (1) | AU2006304868B2 (ja) |
| CA (1) | CA2626698C (ja) |
| HK (1) | HK1126410A1 (ja) |
| WO (1) | WO2007048059A2 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7906489B2 (en) | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
| US7378508B2 (en) | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
| TWI523654B (zh) | 2007-11-27 | 2016-03-01 | 默沙東藥廠 | 抗生素巨環化合物以及其製造及使用之方法 |
| JO3464B1 (ar) | 2013-01-15 | 2020-07-05 | Astellas Pharma Europe Ltd | التركيبات الخاصة بمركبات التياكوميسين |
| CN104846044B (zh) * | 2014-02-17 | 2019-02-01 | 上海医药工业研究院 | 一种提高非达霉素产量的发酵培养基 |
| CN105237599B (zh) * | 2015-10-09 | 2018-10-02 | 华北制药集团新药研究开发有限责任公司 | 闰年霉素a4晶体及其制备方法 |
| CN107714713B (zh) * | 2017-10-25 | 2020-05-26 | 中山大学 | 台勾霉素衍生物在制备治疗登革病毒感染引起的相关疾病和/或症状的药物中的应用 |
| CN107970253B (zh) * | 2017-10-25 | 2020-05-26 | 中山大学 | 台勾霉素衍生物在制备治疗寨卡病毒感染引起的相关疾病和/或症状的药物中的应用 |
| JP7397071B2 (ja) * | 2018-06-07 | 2023-12-12 | アルチュジェン セラピューティクス リミテッド | Ｃ．ディフィシル治療方法及び組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4918174A (en) | 1986-09-26 | 1990-04-17 | Abbott Laboratories | Tiacumicin compounds |
| US5583115A (en) * | 1995-05-09 | 1996-12-10 | Abbott Laboratories | Dialkyltiacumicin compounds |
| WO2006085838A1 (en) * | 2005-01-31 | 2006-08-17 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
| WO2004014295A2 (en) * | 2002-07-29 | 2004-02-19 | Optimer Pharmaceuticals, Inc. | Tiacumicin production |
| SI2070530T1 (sl) * | 2004-05-14 | 2016-05-31 | Merck Sharp & Dohme Corp. | Zdravljenje bolezni, povezanih z uporabo antibiotikov |
-
2006
- 2006-10-23 CN CN2006800479861A patent/CN101340919B/zh not_active Expired - Fee Related
- 2006-10-23 CA CA2626698A patent/CA2626698C/en not_active Expired - Fee Related
- 2006-10-23 EP EP06826544A patent/EP1940417A4/en not_active Withdrawn
- 2006-10-23 AU AU2006304868A patent/AU2006304868B2/en not_active Ceased
- 2006-10-23 CN CN2011103037682A patent/CN102503994A/zh active Pending
- 2006-10-23 JP JP2008536608A patent/JP2009512691A/ja active Pending
- 2006-10-23 KR KR1020087012193A patent/KR101399621B1/ko active IP Right Grant
- 2006-10-23 WO PCT/US2006/041436 patent/WO2007048059A2/en active Application Filing
-
2009
- 2009-06-10 HK HK09105230.0A patent/HK1126410A1/xx not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009512691A5 (ja) | ||
| JP2006526031A5 (ja) | ||
| JP2011518833A5 (ja) | ||
| JP2014500861A5 (ja) | ||
| JP2010504286A5 (ja) | ||
| EP1857457A3 (en) | Benzimidazole derivative and its use as AII receptor antagonist | |
| JP2010536766A5 (ja) | ||
| JP2008513510A5 (ja) | ||
| JP2005518413A5 (ja) | ||
| JP2010077141A5 (ja) | ||
| JP2007092033A5 (ja) | ||
| JP2010530897A5 (ja) | ||
| JP2007302689A5 (ja) | ||
| JP2009502743A5 (ja) | ||
| JP2019516739A5 (ja) | ||
| JP2011527299A5 (ja) | ||
| JP2010508335A5 (ja) | ||
| AR049681A1 (es) | Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas | |
| JP2008517059A5 (ja) | ||
| HRP20080552A2 (en) | Benzimidazole derivative and use thereof | |
| JP2007530703A5 (ja) | ||
| JP2011516610A5 (ja) | ||
| JP2012512863A5 (ja) | ||
| JP2008531701A5 (ja) | ||
| JP2013528659A5 (ja) |